RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber(Cold Spring Harbor Laboratory), Junwei Shi(Cold Spring Harbor Laboratory), Eric Wang(Cold Spring Harbor Laboratory), Amy Rappaport(Cold Spring Harbor Laboratory), Harald Herrmann(Medical University of Vienna), Edward Allan R. Sison(Johns Hopkins University), Daniel Magoon(Johns Hopkins University), Jun Qi(Harvard University), Katharina Blatt(Medical University of Vienna), Mark Wunderlich(Cincinnati Children's Hospital Medical Center), Meredith J. Taylor(Cold Spring Harbor Laboratory), Christopher Johns(Cold Spring Harbor Laboratory), Agustin Chicas(Cold Spring Harbor Laboratory), James C. Mulloy(Cincinnati Children's Hospital Medical Center), Scott C. Kogan(University of California, San Francisco), Patrick A. Brown(Johns Hopkins University), Peter Valent(Medical University of Vienna), James E. Bradner(Harvard University), Scott W. Lowe(Cold Spring Harbor Laboratory), Christopher R. Vakoc(Cold Spring Harbor Laboratory)
Cited by 1,866
Abstract
Related Papers
Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>
John M. Bennett, Daniel Catovsky, Marie‐Theregse Daniel et al.|British Journal of Haematology|1976|5.6k